AMINOPHYLLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aminophylline, and when can generic versions of Aminophylline launch?
Aminophylline is a drug marketed by Abraxis Pharm, Am Regent, Elkins Sinn, Hospira, Intl Medication, King Pharms, Luitpold, Lyphomed, Pharma Serve Ny, Smith And Nephew, Teva Parenteral, Morton Grove, Roxane, Impax Labs, Tablicaps, Vale, Ani Pharms, Ascot, Barr, Chartwell Molecular, Duramed Pharms Barr, Halsey, Hikma Intl Pharms, Kv Pharm, Pal Pak, Panray, Purepac Pharm, Valeant Pharm Intl, Vangard, Vintage Pharms, Watson Labs, and Actavis Mid Atlantic. and is included in fifty-eight NDAs.
The generic ingredient in AMINOPHYLLINE is aminophylline. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aminophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aminophylline
A generic version of AMINOPHYLLINE was approved as aminophylline by HOSPIRA on October 26th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMINOPHYLLINE?
- What are the global sales for AMINOPHYLLINE?
- What is Average Wholesale Price for AMINOPHYLLINE?
Summary for AMINOPHYLLINE
| US Patents: | 0 |
| Applicants: | 32 |
| NDAs: | 58 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Clinical Trials: | 38 |
| DailyMed Link: | AMINOPHYLLINE at DailyMed |
Recent Clinical Trials for AMINOPHYLLINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mahidol University | Phase 2/Phase 3 |
| Medical College of Wisconsin | Phase 1/Phase 2 |
| University of Oklahoma | Phase 1/Phase 2 |
Pharmacology for AMINOPHYLLINE
| Drug Class | Methylxanthine |
Medical Subject Heading (MeSH) Categories for AMINOPHYLLINE
Anatomical Therapeutic Chemical (ATC) Classes for AMINOPHYLLINE
US Patents and Regulatory Information for AMINOPHYLLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | AMINOPHYLLINE | aminophylline | TABLET;ORAL | 084574-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Barr | AMINOPHYLLINE | aminophylline | TABLET;ORAL | 088297-001 | Aug 19, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Purepac Pharm | AMINOPHYLLINE | aminophylline | TABLET;ORAL | 085333-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
